A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07435324 · COMPLETED
Trial details
- NCT number
- NCT07435324
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2025-09-16
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.